Strain differences of hypertension induced by dietary NG-nitro-L-arginine in normotensive rats

Experimental Animals

Volumn 48, Issue 3, 1999, Pages 171-180

  Kawakami, Kohei ^a   Ago, Akio ^a   Gonda, Tatsuo ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

EDRF; Experimental hypertension; L NNA; Rats; Strain differences

Indexed keywords

ANIMALIA; RATTUS NORVEGICUS;

ENZYME INHIBITOR; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POTASSIUM; SODIUM;

ANIMAL; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DIET; DRUG ANTAGONISM; DRUG EFFECT; HYPERTENSION; KIDNEY; MALE; NEPHROSCLEROSIS; ORGAN SIZE; PATHOLOGY; RAT; SPECIES DIFFERENCE; SPRAGUE DAWLEY RAT; URINE; WISTAR KYOTO RAT; WISTAR RAT;

ANIMALS; BLOOD PRESSURE; BODY WEIGHT; DIET; ENZYME INHIBITORS; HYPERTENSION; KIDNEY; MALE; NEPHROSCLEROSIS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; ORGAN SIZE; POTASSIUM; RATS; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SODIUM; SPECIES SPECIFICITY;

EID: 0033158599     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.48.171     Document Type: Article

References (33)

1. G-methylarginine, an inhibitor of endthelium-derived nitric oxide synthesis, is a potent presser agent in the guinea pig: Does nitric oxide regulate blood pressure in vivo? Biochem. Biophys. Res. Comm. 160: 881-886.
2. Alberola, A., Pinilla, J.M., Quesada, T., Romero, J.C., Salom, M.G., and Salazar, F.J. 1992. Role of nitric oxide in mediating renal response to volume expansion. Hypertension 19: 780-784.
3. Baylis, C., Mitruka, B., and Deng, A. 1992. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J. Clin. Invest. 90: 278-281.
4. Blot, S., Arnal, J.F., Xu, Y., Gray, F., and Michel, J.B. 1994. Spinal cord infarcts during long-term inhibition of nitric oxide synthesis in rat. Stroke 25: 1666-1673.
5. Furchgott, R.F. and Zawadzki, J.V. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376.
6. G-nitro-L-arginine methyl ester in conscious Brattleboro rats. Br. J. of Pharmacol. 101: 10-12.
7. Gardiner, S.M., Kemp, P.A., Bennett, T., Palmer, R.M.J., and Moncada, S. 1992. Nitric oxide synthase inhibitors cause sustained, but reversible, hypertension and hindquarters vasoconstriction in Brattleboro rats. Eur. J. of Pharmacol. 213: 449-451.
8. Goureau, O., Lepoivre, M., and Courtois, Y. 1992. Lipopolysaccharide and cytokines induce a macrophage-type of nitric oxide synthase in bovine retinal pigmented epithelial cells. Biochem. Biophys. Res. Comm. 186: 854-859.
9. G-nitro-L-arginine in normotensive Wistar-Kyoto rats. Clin. Exp. Pharmacol. Physiol. 21: 875-879.
10. Heptintall, R.H. 1983. Hypertension, pp. 1347-1454. In: Pathology of the kidney (Heptinstall, R.H), Little Brown & Co. Boston.
11. Huang, P.L., Huang, Z., Mashimo, H., Bloch, K.D., Moskowitz, M.A., Bevan, J.A., and Fishman, M.C. 1995. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242.
12. Ignarro, L.J., Byrns, R.E., Buga, G.M., and Woods, K.S. 1987. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circulation Res. 61: 866-879.
13. G-nitro-L-arginine induces sustained hypertension in normotensive Wistar-Kyoto rats. Clin. Exp. Pharmacol. Physiol. 19: 583-586.
14. Ikeda, K., Nara, Y., Tagami, M., and Yamori, Y. 1997. Nitric oxide deficiency induces myocardial infarction in hypercholesterolaemic stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 24: 344-348.
15. Kawakami, K., Ago, A., and Gonda, T. 1996. Evaluation of an automated blood pressure analyzer; UR-5000. J. Exp. Anim. Technol. 31: 115-122 (in Japanese).
16. Kobayashi, Y., Ikeda, K., Kakizoe, E., Shinozuka, K., Nara, Y., Yamori, Y., and Hattori, K. 1991. Comparison of vasopressor effects of nitro arginine in stroke-prone spontaneously hypertensive rats and Wistar-Kyoto rats. Clin. Exp. Pharmacol. Physiol. 18: 599-604.
17. Kobayashi, Y. and Hattori, K. 1990. Nitroarginine inhibits endothelium-derived relaxation. Japan J. Pharmacol. 52: 167-169.
18. Kurtz, T.W., Montano, M., Chan, L., and Kabra, P. 1989. Molecular evidence of genetic heterogeneity in Wistar-Kyoto rats: Implications for research with the spontaneously hypertensive rat. Hypertension 13: 188-192.
19. Mattson, D.L., Roman, R.J., and Cowley, A.W. 1992. Role of nitric oxide in renal papillary blood flow and sodium excretion. Hypertension 19: 766-769.
20. McCall, T.B., Palmer, R.M.J., and Moncada, S. 1991. Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone. Eur. J. Immunol. 21: 2523-2527.
21. G-nitroarginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endthelium-dependent vasodilation in vitro. Br. J. Pharmacol. 99: 408-412.
22. 5 [imino-(nitroamino) methyl] - L-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitro oxide synthesis from L-arginine. Naunyn-Schmiedeberg's Arc. Pharmacol. 341: 143-147.
23. Nabika, T., Kara, Y., Ikeda, K., Endo, J., and Yamori, Y. 1991. Genetic heterogeneity of the spontaneously hypertensive rats. Hypertension 18: 12-16.
24. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB Journal. 6: 3051-3064.
25. Palmer, R.M.J., Ashton, D.S., and Moncada, S. 1988. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666.
26. Rees, D.D., Palmer, R.M.J., and Mocada, S. 1989. Role of endthelium-derived nitric oxide in the regulation of blood pressure. Proc. Nat. Acad. Sci. USA. 86: 3375-3378.
27. Ribeiro, M.O., Autunes, E., G. de Nucci., Lovisolo, S. M., and Zatz, R. 1992. Chronic inhibition of nitric oxide synthesis. Hypertension 20: 298-303.
28. Salazar, F.J., Pinilla, J.M., Lopez, F., Romero, J.C., and Quesada, T. 1992. Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide. Hypertension 20: 113-117.
29. Stoos, B.A., Carretero, O.A., Farhy, R.D., Scicli, G., and Garvin, J.L. 1992. Endothelium-derived relaxing factor inhibits transport and increases cGMP content in cultured mouse cortical collecting duct cells. J. Clin. Invest. 89: 761-765.
30. Tomita, T., Ezaki, M., Miwa, M., Nakamura, K., and Inoue, Y. 1990. Rapid and reversible inhibition by low density lipoprotein of endothelial dependent relaxation to hemostatic substances in porcine coronary arteries. Circulation Res. 66: 18-27.
31. G-nitro-arginine on the synthesis of EDRF and the cerebroarterial response to vasodilator nerve stimulation. Life Science 47: 345-351.
32. Yamori, Y., Ikeda, K., Mizushima, S., Nara, Y., and Tagami, M. 1992. Induction of malignant hypertensive in stroke-prone spontaneously hypertensive rats (SHRSP) -treated with nitroarginine, an inhibitor of endothelium -derived relaxing factor (EDRF). Genetic Hypertension 218: 23-25.
33. Yamori, Y. 1989. Predictive and preventive pathology of cardiovascular diseases. Acta Pathologica Japonica 39: 683-705.